References
- Sibai B, Dekker G, Kupferminc M. Preeclampsia. Lancet 2005; 365(9461)785–799
- Sibai BM, Caritis S, Hauth J, Lindheimer M, VanDorsten JP, MacPherson C, et al. Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National Institute of Child Health and Human Development Network of Maternal–Fetal Medicine Units. Am J Obstet Gynecol 2000; 182(2)364–369
- Lindheimer MD, Umans JG. Explaining and predicting preeclampsia. N Engl J Med 2006; 355(10)1056–1058
- Rovere-Querini P, Castiglioni MT, Sabbadini MG, Manfredi AA. Signals of cell death and tissue turnover during physiological pregnancy, preeclampsia, and autoimmunity. Autoimmunity 2007; 40(4)290–294
- Manfredi AA, Rovere-Querini P, Bottazzi B, Garlanda C, Mantovani A. Pentraxins, humoral innate immunity and tissue injury. Curr Opin Immunol 2008; 20(5)538–544
- Rovere-Querini P, Antonacci S, Dell'Antonio G, Angeli A, Almirante G, Cin ED, et al. Plasma and tissue expression of the long pentraxin 3 during normal pregnancy and preeclampsia. Obstet Gynecol 2006; 108(1)148–155
- Cetin I, Cozzi V, Pasqualini F, Nebuloni M, Garlanda C, Vago L, et al. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol 2006; 194(5)1347–1353
- Assi F, Fruscio R, Bonardi C, Ghidini A, Allavena P, Mantovani A, et al. Pentraxin 3 in plasma and vaginal fluid in women with preterm delivery. BJOG 2007; 114(2)143–147
- Huppertz B. Placental origins of preeclampsia: Challenging the current hypothesis. Hypertension 2008; 51(4)970–975
- Landon MB. Diabetic nephropathy and pregnancy. Clin Obstet Gynecol 2007; 50(4)998–1006